TITLE

IMS Health Launches Strategic Review

AUTHOR(S)
Davis, Avram
PUB. DATE
October 2009
SOURCE
Mergers & Acquisitions Report;10/26/2009, Vol. 22 Issue 43, p7
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the exploration of strategic alternatives by IMS Health Incorporated, a provider of data and market information for pharmaceutical and healthcare companies, as of October 2009. IMS is said to be in talks to sell the firm to a private-equity buyer according to "The Wall Street Journal." TPG, Silver Lake and BC Partners are said to be interested in IMS, and the latter could fetch as much as 3.5 billion dollars.
ACCESSION #
44860770

 

Related Articles

  • IMS talks merger, data-mining fears ease. Iskowitz, Marc // Medical Marketing & Media;Jan2010, Vol. 45 Issue 1, p9 

    The article reports that IMS Health Inc. conducted a meeting to vote on the buyout offer worth 4.2 billion dollars which is said to restore investors' confidence.

  • IMS accused of monopolising German market.  // Life Science Today;Apr2001, Vol. 2 Issue 2, p6 

    Reports on the European Commission's statement of objection to IMS Health Inc. for the imposition of interim measures against the company in line with the refusal of IMS to grant a license to the Commission's regional sales data method in Germany. Allegation of IMS Health's abuse of a dominant...

  • IMS: 'Pharmerging' to propel Rx growth farther. DeArment, Alaric // Drug Store News;5/17/2010, Vol. 32 Issue 6, p66 

    The article reports on the prediction made by market research firm IMS Health Inc. on the possibility of pharmaceuticals to become a global market worth more than 1 trillion dollars within four years.

  • Launches.  // Pharmaceutical Executive;Dec2003, Vol. 23 Issue 12, p96 

    Reports on developments related to the pharmaceutical industry in the U.S. as of December 2003. Renaming of S.G. Madison to Cadent Medical Communications; Sales force of IMS Health.

  • IMS Introduces Services To Assist Rx Marketers.  // Chain Drug Review;3/15/2010, Vol. 32 Issue 6, p77 

    The article reports on the launch of the IMS Aggregate Spend Compliance Services by IMS Health Inc. to help pharmaceutical companies about marketing disclosures laws in the U.S.

  • Global drug sales. Kondro, Wayne // CMAJ: Canadian Medical Association Journal;11/23/2010, Vol. 182 Issue 17, pE758 

    The article reports on the statement by the pharmaceutical industry market intelligence firm IMS Health Inc. in a press release that the world pharmaceutical market will grow between 5% and 7% in 2011 or 880 billion dollars.

  • Pharma markets expected to grow globally in 2011. Arnold, Matthew // Medical Marketing & Media;Nov2010, Vol. 45 Issue 11, p8 

    The article reports on the expected global market growth of the pharmaceutical industry in 2011, based on the forecast of research firm IMS Health Inc.

  • Manufacturer Rx sales top $120 billion, IMS reports. Ukens, Carol // Drug Topics;3/20/2000, Vol. 144 Issue 6, p34 

    Reports on the sales of pharmaceutical manufacturers in 1999 according to IMS Health. Factors that influenced the increase in drug sales; Sales of prescription drugs; Outlook of the pharmaceutical market.

  • Update.  // Medical Marketing & Media;Jun2011, Vol. 46 Issue 6, p10 

    The article offers information on various topics related to pharmaceutical industry including the appointment of Damian Braga as global head of commercial operation of Sanofi Pasteur SA, the report of IMS Health Inc. regarding the expected 3-6% decrease in spending on medicine, and the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics